Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus

Summary

In this study researchers want to learn more about the effectiveness of Iberogast® in patients with irritable stomach and concomitant chronic or recurrent heartburn and backward flow of stomach liquid into the esophagus. 60 patients in the age range from 18 - 80 year will be treated over 4 weeks with Iberogast® or placebo - an inactive substance which looks identical to Iberogast®. Patients completed diaries will provide researchers with detailed information on the change of stomach and intestinal symptoms during the treatment period. In addition information on the acidity of the esophagus and stomach liquid will be collected.

Timeline

Start

2009-06-18

Primary completion

2013-05-03

Completion

2013-05-03

Drugs

Indications

No indication recorded.